Jun 22, 2020
Dracen announces two DRP-104 presentations at AACR
Jun 18, 2020
Aridis Pharmaceuticals to Discuss APEX(TM) in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
Jun 02, 2020
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
May 27, 2020
Compugen Doses First Patient in COM701 Phase 1 Monotherapy Expansion Cohort
May 06, 2020
Compugen Reports First Quarter 2020 Results
Apr 22, 2020
Compugen Expands Intellectual Property Portfolio for COM701 With New European Composition of Matter Patent
Apr 06, 2020
Compugen Announces First Patient Dosed in COM902 Phase 1 Trial for Patients With Advanced Malignancies
Feb 20, 2020
Compugen Reports Fourth Quarter and Full Year 2019 Results
Feb 04, 2020
Compugen Announces New U.S. Patent for Methods of Screening for Anti-PVRIG Antibodies
Jan 29, 2020
Compugen Further Expands Intellectual Property Portfolio With New European Patent for Anti-PVRIG Antibodies
Jan 23, 2020
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
Jan 20, 2020
Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody
Dec 11, 2019
Study Reveals Mechanisms that Help Pancreatic Cancer Cells Avert Starvation
Nov 11, 2019
Compugen Reports Third Quarter 2019 Results
Nov 06, 2019
Compugen Expands Patent Portfolio for COM902 with New Composition of Matter and Use Patent in Europe
Nov 05, 2019
Compugen Presents Initial Clinical Data from Ongoing Phase 1 Trial of COM701 in Patients with Advanced Solid Tumors at SITC 2019
Nov 04, 2019
Dracen Pharmaceuticals announces DRP-104 presentations at the 2019 Society of Immunotherapy of Cancer (SITC) Meeting
Oct 07, 2019
Helixmith shows long-term safety and efficacy of VM202 for painful DPN patients in DPN phase 3-1b extension study
Oct 02, 2019
BerGenBio to Present Clinical Data From Phase II Trial With Selective AXL Inhibitor at 34th Annual SITC Meeting
Oct 02, 2019
Compugen to Present Data from Ongoing COM701 Phase 1 Clinical Trial at SITC 2019